Immunohistochemical determination of HER-2/neu overexpression in malignant melanoma reveals no prognostic value, while c-Kit (CD117) overexpression exhibits potential therapeutic implications

Immunohistochemical determination of HER-2/neu overexpression in malignant melanoma reveals no prognostic value, while c-Kit (CD117) overexpression exhibits potential therapeutic implications

<p>Abstract</p> <p>Background</p> <p>HER-2/neu and c-kit (CD117) onco-protein are increasingly being recognized as targets for therapy in solid tumors, but data on their role in malignant melanoma is currently limited. We studied the prevalence of overexpressi...

Full description

Bibliographic Details
Main Authors:	Potti Anil, Koch Michael, Hille Rachel
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2003-01-01
Series:	Journal of Carcinogenesis
Online Access:	http://www.carcinogenesis.com/content/2/1/8

Similar Items

HER-2/<it>neu </it>and CD117 (c-kit) overexpression in patients with pesticide exposure and extensive stage small cell lung carcinoma (ESSCLC)
by: Potti Anil, et al.
Published: (2005-06-01)

HER-2/neu overexpression in breast cancer
by: Rana S. Aziz, et al.
Published: (2010-10-01)

Suppression of HER2/Neu-Overexpressing Cancers by siRNA against HER2/Neu Proto-Oncogene
by: Zong-Keng Kuo, et al.
Published: (2006)

Overexpression of HER-2/neu Oncogene and Transitional Cell Carcinoma of Bladder
by: Farid Zaeri, et al.
Published: (2007-02-01)

3, 3’-diindolylmethane induces apoptosis through reduction of HER2/neu in HER2/neu-overexpressing ovarian and breast cancers
by: Chan-Fan Liang, et al.
Published: (100)

HER-2/neu overexpression in invasive ductal breast cancer: An association with other prognostic and predictive factors
by: Ivković-Kapicl Tatjana, et al.
Published: (2007-01-01)

Silencing of the HER2/neu Gene by siRNA Inhibits Proliferation and Induces Apoptosis in HER2/neu-Overexpressing Breast Cancer Cells
by: Timo Faltus, et al.
Published: (2004-11-01)

Curcumin derivatives preferentially inhibit the proliferation of HER2/neu-overexpressing cancer cells
by: Yi-ching Lee, et al.
Published: (2009)

Berberine may inhibit cell proliferation and metastasis via degradation of p185HER2/neu in HER2/neu-overexpressing cancer cells
by: Ying-Yu Lin, et al.
Published: (2008)

The Anticancer Effect of Baicalein on p185HER2/neu Overexpressing Ovarian Cancer Cells
by: Guan-Shiun Fang, et al.
Published: (2009)

Clinical Relevance of HER-2/neu Overexpression in Patients With Testicular Nonseminomatous Germ Cell Tumor
by: Mohammad Reza Ghavamnasiri, et al.
Published: (2010-03-01)

The anticancer effect of Antrodia camphorata (AC-10) on HER-2/neu-overexpressing cancer cells
by: Ying-Chen Juan, et al.
Published: (2010)

Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma
by: Yan W, et al.
Published: (2018-03-01)

Induction of Apoptosis in HER-2/neu-overexpressing Cancer Cells by Simian Virus 40 T/t-common Polypeptide
by: Cheng Shih An, et al.
Published: (2003)

Suppression of the Tumorigenicity of the HER-2/neu-overexpressing Cancer Cells by the Simian Virus 40 T/t-Common Polypeptide
by: You-Chin Lin, et al.
Published: (2000)

OVEREXPRESSION OF P53 PROTEIN IN MALIGNANT BREAST TUMORS: AN IMMUNOHISTOCHEMICAL STUDY
by: S. Makjoub, et al.
Published: (1999-03-01)

OVEREXPRESSION OF P53 PROTEIN IN MALIGNANT BREAST TUMORS: AN IMMUNOHISTOCHEMICAL STUDY
by: S. Makjoub, et al.
Published: (1999-06-01)

Societal Costs and Benefits of Treatment with Trastuzumab in Patients with Early HER2neu-Overexpressing Breast Cancer in Singapore
by: de Lima Lopes Gilberto
Published: (2011-05-01)

SV40 T/t-Common Polypeptide Specifically Induces Apoptosis in Human Cancer Cells that Overexpress HER2/neu
by: Chun-Chiang Wen, et al.
Published: (2007)

Adenoid cystic carcinoma of the breast: Report of two cases with immunohistochemical profile of C-kit and MYB overexpression
by: Susie Chin, et al.
Published: (2014-01-01)

Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status
by: Anogiannaki Nektaria, et al.
Published: (2005-02-01)

Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma
by: Axel Walch, et al.
Published: (2000-01-01)

Her-2/neu overexpression is associated with thrombospondin-1-related angiogenesis and thrombospondin-1-unrelated lymphangiogenesis in breast cancer
by: Ming-Chuan Hong, et al.
Published: (2013-11-01)

HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer
by: Luo H, et al.
Published: (2021-04-01)

KIT overexpression and a deletion in c-kit gene of canine hemangiosarcomas
by: Yi-Chen Chen, et al.
Published: (2012)

Prognostic value of immunohistochemical marker HER2/neu in patients resected for gastric cancer stage IIIA
by: O. M. Levyk
Published: (2014-04-01)

Immunohistochemical Expression of HER2/neu Receptors in Iraqi Patients with Endometrioid Carcinoma
by: Zinah Hussein Abd Ali, et al.
Published: (2018-11-01)

Immunohistochemical expression of HER-2/NEU-CERBB-2 in patients with adenocarcinoma of the stomach
by: Fernando K Cirne-Lima, et al.

Chloroquine supplementation increases the cytotoxic effect of curcumin against Her2/neu overexpressing breast cancer cells in vitro and in vivo in nude mice while counteracts it in immune competent mice
by: L. Masuelli, et al.
Published: (2017-11-01)

ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
by: Yu. S. Shatova, et al.
Published: (2017-12-01)

Trastuzumab mediated T-cell response against HER-2/neu overexpressing esophageal adenocarcinoma depends on intact antigen processing machinery.
by: Francesca Milano, et al.
Published: (2010-08-01)

Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)
by: Alessandro D. Santin, et al.
Published: (2017-02-01)

Enhancement of Etoposide- or Irradiation-Induced Apoptosis in HER-2/neu-overexpressing Cancer Cells by Simian Virus 40 T/t-common Polypeptide
by: Chou-Hua Kuo, et al.
Published: (2005)

Immunohistochemical expression of HER2/neu in colorectal carcinoma in Erbil city, Kurdistan Region
by: Lilav Adel Kamal, et al.
Published: (2019-12-01)

Expression of E- and N-cadherins in tumor in luminal, primary operable breast cancer without Her2/neu overexpression in postmenopausal women as a prognostic factor
by: V. V. Tokmakov, et al.
Published: (2020-12-01)

A New Monoclonal Antibody Demonstrates That Muc4, the Intramembrane Ligand for Erbb2/Her2/Neu, Is Overexpressed in Multiple Carcinomas
by: Jin Zhang, et al.
Published: (2002-01-01)

Inhibition of Cell Growth and Induction of Apoptosis by Antrodia camphorata in HER-2/neu-Overexpressing Breast Cancer Cells through the Induction of ROS, Depletion of HER-2/neu, and Disruption of the PI3K/Akt Signaling Pathway
by: Chuan-Chen Lee, et al.
Published: (2012-01-01)

Expression level of androgen receptors in tumor tissue and its prognostic significance in primary operable luminal breast cancer without overexpression of Her2/neu in postmenopausal women
by: O I Kit, et al.
Published: (2019-12-01)

Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy
by: Rodrigues Loreta M, et al.
Published: (2012-05-01)

Lapatinib for HER2 overexpressing breast cancer
by: Jones, Jeremy, et al.
Published: (2009)

Cannot write session to /tmp/vufind_sessions/sess_i7b7hfc9kkuncntrfboofsscil